Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress

Gethin R. Ellis; Angus K. Nightingale; Daniel J. Blackman; Richard A. Anderson; Catherine Mumford; Graham Timmins; Derek Lang; Simon K. Jackson; Michael D. Penney; Malcolm J. Lewis; Michael P. Frenneaux; Jayne Morris-Thurgood

doi:10.1016/S1388-9842(02)00002-8

Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress

Gethin R. Ellis^*, Angus K. Nightingale, Daniel J. Blackman, Richard A. Anderson, Catherine Mumford, Graham Timmins, Derek Lang, Simon K. Jackson, Michael D. Penney, Malcolm J. Lewis, Michael P. Frenneaux, Jayne Morris-Thurgood

^*Corresponding author for this work

School of Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	193-199
Number of pages	0
Journal	European Journal of Heart Failure
Volume	4
Issue number	2
DOIs	https://doi.org/10.1016/S1388-9842(02)00002-8
Publication status	Published - 2002

Keywords

heart failure
angiotensin
drugs
endothelium
free radicals

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1388-9842(02)00002-8

Cite this

Ellis, G. R., Nightingale, A. K., Blackman, D. J., Anderson, R. A., Mumford, C., Timmins, G., Lang, D., Jackson, S. K., Penney, M. D., Lewis, M. J., Frenneaux, M. P., & Morris-Thurgood, J. (2002). Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress. European Journal of Heart Failure, 4(2), 193-199. https://doi.org/10.1016/S1388-9842(02)00002-8

@article{95f97ce35c6440fe86a4afd3f65e0c69,

title = "Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress",

keywords = "heart failure, angiotensin, drugs, endothelium, free radicals",

author = "Ellis, {Gethin R.} and Nightingale, {Angus K.} and Blackman, {Daniel J.} and Anderson, {Richard A.} and Catherine Mumford and Graham Timmins and Derek Lang and Jackson, {Simon K.} and Penney, {Michael D.} and Lewis, {Malcolm J.} and Frenneaux, {Michael P.} and Jayne Morris-Thurgood",

year = "2002",

doi = "10.1016/S1388-9842(02)00002-8",

language = "English",

volume = "4",

pages = "193--199",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley-Blackwell",

number = "2",

}

Ellis, GR, Nightingale, AK, Blackman, DJ, Anderson, RA, Mumford, C, Timmins, G, Lang, D, Jackson, SK, Penney, MD, Lewis, MJ, Frenneaux, MP & Morris-Thurgood, J 2002, 'Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress', European Journal of Heart Failure, vol. 4, no. 2, pp. 193-199. https://doi.org/10.1016/S1388-9842(02)00002-8

TY - JOUR

T1 - Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress

AU - Ellis, Gethin R.

AU - Nightingale, Angus K.

AU - Blackman, Daniel J.

AU - Anderson, Richard A.

AU - Mumford, Catherine

AU - Timmins, Graham

AU - Lang, Derek

AU - Jackson, Simon K.

AU - Penney, Michael D.

AU - Lewis, Malcolm J.

AU - Frenneaux, Michael P.

AU - Morris-Thurgood, Jayne

PY - 2002

Y1 - 2002

KW - heart failure

KW - angiotensin

KW - drugs

KW - endothelium

KW - free radicals

U2 - 10.1016/S1388-9842(02)00002-8

DO - 10.1016/S1388-9842(02)00002-8

M3 - Article

SN - 1388-9842

VL - 4

SP - 193

EP - 199

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 2

ER -